GSK financials
GSK (GSK) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
GSK income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $32.67B | $23.65B | $8.34B | $5.72B | 2.78 |
| 2024 | $31.38B | $22.33B | $4.02B | $2.58B | 1.24 |
| 2023 | $30.33B | $21.76B | $6.75B | $4.93B | 2.40 |
| 2022 | $29.32B | $19.77B | $6.43B | $14.96B | 7.32 |
| 2021 | $24.70B | $16.53B | $4.36B | $4.38B | 2.70 |
| 2020 | $24.35B | $16.43B | $5.98B | $5.75B | 2.86 |
- GSK revenue was $32.67B in fiscal 2025, net income $5.72B.
Updated 2026-11-02 19:54 UTC